Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Senti Biosciences is a biotech company developing cell and gene therapies using proprietary gene circuit platform technologies. Its focus is on engineering smarter, programmable therapies for cancer and other diseases, primarily through off-the-shelf CAR-NK cell products targeting hematologic and solid tumors. The company emphasizes precision, safety, and control in immunotherapy, leveraging synthetic biology, strategic collaborations, and advanced manufacturing to address unmet medical needs.
This description was generated via AI from an annual report. Updated about 1 year ago.